Belite Bio, Inc. ADR ( (BLTE) ) just unveiled an update.
On March 18, 2025, Belite Bio, Inc announced its upcoming annual general meeting of shareholders, scheduled for April 15, 2025. The meeting will address several resolutions, including the re-election of directors and the removal and election of certain board members. This announcement is significant for stakeholders as it outlines key leadership decisions that could impact the company’s strategic direction and governance.
More about Belite Bio, Inc. ADR
Belite Bio, Inc is a company based in San Diego, California, involved in the biotechnology industry. The company focuses on developing treatments for eye diseases and metabolic disorders, aiming to address significant unmet medical needs.
YTD Price Performance: 4.71%
Average Trading Volume: 44,455
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.08B
For an in-depth examination of BLTE stock, go to TipRanks’ Stock Analysis page.